* OPKO Health Inc OPK.OQ OPK.O is expected to show a
fall in
quarterly revenue when it reports results
* The Miami Florida-based company is expected to report a
2.7% decrease in revenue to $174.778 million from $179.7 million
a year ago, according to the mean estimate from 6 analysts,
based on LSEG data. The company's guidance on August 3 2023, for
the period ended September 30, was for revenue between $165.00
million and $180.00 million.
* Refinitiv's mean analyst estimate for OPKO Health Inc is
for a
loss of 10 cents per share.
* The current average analyst rating on the shares is
"strong buy"
and the breakdown of recommendations is 6 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell."
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* Wall Street's median 12-month price target for OPKO Health
Inc
is $4, above its last closing price of $1.35.
Previous quarterly performance (using preferred earnings measure
in US dollars).
QUARTER STARMINESM REFINITIV ACTUAL BEAT, SURPRI
ENDING ARTESTIMAT IBES MET, SE %
E® ESTIMATE MISSED
Jun. 30 2023 -0.07 -0.07 -0.03 Beat 63.6
Mar. 31 2023 -0.08 -0.08 -0.02 Beat 73.9
Dec. 31 2022 -0.11 -0.11 -0.11 Met 2.9
Sep. 30 2022 -0.08 -0.08 -0.11 Missed -31
Jun. 0.01 0.01 -0.14 Missed -1,850
30 2022
Mar. 31 2022 -0.06 -0.06 -0.08 Missed -42.9
Dec. 31 2021 -0.02 -0.02 -0.11 Missed -450
Sep. 30 2021 -0.01 -0.01 0.00 Beat 100
This summary was machine generated November 4 at 01:32 GMT. All
figures in US dollars unless otherwise stated